EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The beneficial effect of fluoxetine on behavioral and cognitive changes in chronic experimental Chagas disease unveils the role of serotonin fueling astrocyte infection by Trypanosoma cruzi

Glaucia Vilar-Pereira, Daniel Gibaldi, Leda Castaño-Barrios, Andrea Alice da Silva, Isabela Resende Pereira, Otacílio Cruz Moreira, Constança Britto, Hílton Antônio Mata Dos Santos, Raquel de Oliveira Lopes, Luzineide Wanderley Tinoco, Wilson Oliveira, Joseli Lannes-Vieira iD

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Glaucia Vilar-Pereira und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biologia das Interações, Instituto Oswaldo Cruz/Fiocruz, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Fluoxetine, Chagas Disease, Trypanosoma cruzi, Serotonin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Brasil, Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq, Scientist of the State of Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background In Chagas disease (CD), a neglected tropical disease caused by the parasite Trypanosoma cruzi , the development of mental disorders such as anxiety, depression, and memory loss may be underpinned by social, psychological, and biological stressors. Here, we investigated biological factors underlying behavioral changes in a preclinical model of CD. Methodology/Principal Findings In T . cruzi -infected C57BL/6 mice, a kinetic study (5 to 150 days postinfection, dpi) using standardized methods revealed a sequential onset of behavioral changes: reduced innate compulsive behavior, followed by anxiety and depressive-like behavior, ending with progressive memory impairments. Hence, T . cruzi -infected mice were treated (120 to 150 dpi) with 10 mg/Kg/day of the selective serotonin reuptake inhibitor fluoxetine (Fx), an antidepressant that favors neuroplasticity. Fx therapy reversed the innate compulsive behavior loss, anxiety, and depressive-like behavior while preventing or reversing memory deficits. Biochemical, histological, and parasitological analyses of the brain tissue showed increased levels of the neurotransmitters GABA/glutamate and lipid peroxidation products and decreased expression of brain-derived neurotrophic factor in the absence of neuroinflammation at 150 dpi. Fx therapy ameliorated the neurochemical changes and reduced parasite load in the brain tissue. Next, using the human U-87 MG astroglioma cell line, we found no direct effect of Fx on parasite load. Crucially, serotonin/5-HT (Ser/5-HT) promoted parasite uptake, an effect increased by prior stimulation with IFNγ and TNF but abrogated by Fx. Also, Fx blocked the cytokine-driven Ser/5-HT-promoted increase of nitric oxide and glutamate levels in infected cells. Conclusion/Significance We bring the first evidence of a sequential onset of behavioral changes in T . cruzi -infected mice. Fx therapy improves behavioral and biological changes and parasite control in the brain tissue. Moreover, in the central nervous system, cytokine-driven Ser/5-HT consumption may favor parasite persistence, disrupting neurotransmitter balance and promoting a neurotoxic environment likely contributing to behavioral and cognitive disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoxetineChagas DiseaseTrypanosoma cruziSerotoninMice, Inbred C57BLAstrocytesAnimalsMiceDisease Models, AnimalBrainBehavior, AnimalMaleHumansSelective Serotonin Reuptake InhibitorsCognitionDepressionParasite LoadAnxiety

Substanzen

FluoxetineSerotoninSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Laboratório de Biologia das Interações, Instituto Oswaldo Cruz/Fiocruz, Rio de Janeiro, Brazil.
  • Laboratório Multidisciplinar de Apoio à Pesquisa em Nefrologia e Ciências Médicas, Departamento de Patologia, Faculdade de Medicina, Universidade Federal Fluminense, Niterói, Brazil.
  • Laboratório de Virologia e Parasitologia Molecular, IOC/Fiocruz, Rio de Janeiro, Brazil.
  • Laboratório de Biologia Molecular e Doenças Endêmicas, IOC/Fiocruz, Rio de Janeiro, Brazil.
  • Escola de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Laboratório de Análise e Desenvolvimento de Inibidores Enzimáticos, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Joseli Lannes-Vieira

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Brasil
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq
  • Scientist of the State of Rio de Janeiro
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Fundação Oswaldo Cruz

Zitieren

APA

Vilar-Pereira, G., Gibaldi, D., Castaño-Barrios, L., da Silva, A. A., Resende Pereira, I., Cruz Moreira, O., Britto, C., Mata Dos Santos, H. A., de Oliveira Lopes, R., Wanderley Tinoco, L., Oliveira, W., & Lannes-Vieira, J. (2024). The beneficial effect of fluoxetine on behavioral and cognitive changes in chronic experimental Chagas disease unveils the role of serotonin fueling astrocyte infection by Trypanosoma cruzi. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012199

Vancouver

Vilar-Pereira G, Gibaldi D, Castaño-Barrios L, da Silva AA, Resende Pereira I, Cruz Moreira O, et al. The beneficial effect of fluoxetine on behavioral and cognitive changes in chronic experimental Chagas disease unveils the role of serotonin fueling astrocyte infection by Trypanosoma cruzi. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012199

BibTeX
@article{VilarPereira2024,
  author = {Vilar-Pereira, Glaucia and Gibaldi, Daniel and Castaño-Barrios, Leda and da Silva, Andrea Alice and Resende Pereira, Isabela and Cruz Moreira, Otacílio and Britto, Constança and Mata Dos Santos, Hílton Antônio and de Oliveira Lopes, Raquel and Wanderley Tinoco, Luzineide and Oliveira, Wilson and Lannes-Vieira, Joseli},
  title = {The beneficial effect of fluoxetine on behavioral and cognitive changes in chronic experimental Chagas disease unveils the role of serotonin fueling astrocyte infection by Trypanosoma cruzi},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012199}
}
Kostenlos starten →